|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-11-11
|
|
pubmed:abstractText |
Encouraging evidence of clinical benefits from cancer immunotherapy is beginning to accumulate in several clinical trials. Cancer immunotherapy is based on two main methods, active vaccination and cell-transfer therapy. The ex vivo expansion of T cells is required to monitor vaccine-induced antigen-specific T cells or prepare large numbers of reactive lymphocytes for adoptive transfer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1477-2566
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
936-46
|
|
pubmed:meshHeading |
pubmed-meshheading:19903105-Antibodies, Monoclonal,
pubmed-meshheading:19903105-Antigens, CD3,
pubmed-meshheading:19903105-Cell Proliferation,
pubmed-meshheading:19903105-Cells, Cultured,
pubmed-meshheading:19903105-Culture Media, Conditioned,
pubmed-meshheading:19903105-Cytotoxicity, Immunologic,
pubmed-meshheading:19903105-Humans,
pubmed-meshheading:19903105-Immunotherapy, Adoptive,
pubmed-meshheading:19903105-Lymphocyte Activation,
pubmed-meshheading:19903105-Neoplasms,
pubmed-meshheading:19903105-Serum,
pubmed-meshheading:19903105-T-Lymphocytes
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Impact of culture medium on the expansion of T cells for immunotherapy.
|
|
pubmed:affiliation |
Department of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
